Menu
Not yet recruiting NCT07196917

Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China

— Observational Cardiovascular Diseases Respiratory Tract Diseases Cancer Endocrine System Diseases

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Cardiovascular Diseases, Respiratory Tract Diseases, Cancer, Endocrine System Diseases. Basic parameters: 30 years — 74 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

To further explore the application prospects of integrated Traditional Chinese and Western medicine in chronic disease prevention and control and health management, this study intends to establish a large, prospective, integrated Traditional Chinese and Western medicine cohort in Hubei Province. This study will conduct long-term follow-up and multi-dimensional data collection to systematically reveal the associations between Traditional Chinese Medicine (TCM) constitution types and chronic diseases, the aging process, and multi-morbidity, thereby developing an integrated health management strategy with local characteristics. This study will fill the current gap in systematic evidence linking TCM constitutions to the prevalence of modern diseases, providing a solid demographic and biological foundation for the integrated development of Traditional Chinese and Western medicine. It will also contribute to meeting the needs for early disease warning, early intervention, and personalized care under the "Healthy China" strategic goal.

Primary outcome measures

  • Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China [Time frame: From enrollment to the 10-year follow-up]
  • Incidence of major chronic diseases (coronary heart disease, stroke, diabetes, COPD, lung cancer, colorectal cancer, gastric cancer, liver cancer, and esophageal cancer) [Time frame: From baseline (enrollment) to 10-year follow-up Measurement Tool: Standardized physician-adjudicated diagnosis based on ICD-10 codes, confirmed through hospital electronic medical records and disease registries]
Secondary outcome measures (1)
  • All-cause mortality [Time frame: From baseline to 10-year follow-up]

Eligibility criteria

Inclusion criteria

Age: Participants aged 30 to 74 years

Physical Functionality: Free from severe physical disabilities impacting mobility or communication, with preserved ability to comprehend and respond to study procedures

Informed Consent: Capable of providing written informed consent voluntarily after receiving full study disclosure

Exclusion criteria

Residents living in functional areas (e.g., work sheds, military units, student dormitories, nursing homes, etc.)

Individuals unable to communicate normally

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07196917 · 2023ZD0S09900)

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗